Hideki Sakai

3.4k total citations
192 papers, 2.5k citations indexed

About

Hideki Sakai is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Hideki Sakai has authored 192 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pulmonary and Respiratory Medicine, 43 papers in Surgery and 34 papers in Oncology. Recurrent topics in Hideki Sakai's work include Prostate Cancer Treatment and Research (40 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Bladder and Urothelial Cancer Treatments (19 papers). Hideki Sakai is often cited by papers focused on Prostate Cancer Treatment and Research (40 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Bladder and Urothelial Cancer Treatments (19 papers). Hideki Sakai collaborates with scholars based in Japan, Canada and United States. Hideki Sakai's co-authors include Yasuyoshi Miyata, Hiroshi Kanetake, Tomohiro Matsuo, Izumi Nagata, Nobuyuki Sakai, Kojiro Ohba, Yutaka Saito, Koji Iihara, Kenichi Murao and Toshio Higashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Physiology.

In The Last Decade

Hideki Sakai

184 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Sakai Japan 25 993 490 474 458 346 192 2.5k
Ettore Mearini Italy 32 833 0.8× 196 0.4× 683 1.4× 714 1.6× 206 0.6× 137 2.6k
Sachiyo Suita Japan 31 692 0.7× 749 1.5× 958 2.0× 1.8k 3.9× 265 0.8× 239 3.8k
Nicola J. Mutch United Kingdom 28 892 0.9× 225 0.5× 360 0.8× 340 0.7× 396 1.1× 67 3.6k
Po‐Hui Chiang Taiwan 26 625 0.6× 363 0.7× 158 0.3× 591 1.3× 185 0.5× 126 2.2k
E. Kunze Germany 28 445 0.4× 813 1.7× 401 0.8× 825 1.8× 225 0.7× 117 2.4k
Barry S. Oemar Switzerland 25 781 0.8× 152 0.3× 1.6k 3.4× 424 0.9× 401 1.2× 51 3.8k
Satoshi Suzuki Japan 27 564 0.6× 120 0.2× 686 1.4× 262 0.6× 269 0.8× 124 2.2k
Giovanni Battista Doglietto Italy 33 955 1.0× 237 0.5× 592 1.2× 1.6k 3.5× 345 1.0× 119 3.4k
Hirohiko Yamabe Japan 34 637 0.6× 346 0.7× 602 1.3× 906 2.0× 380 1.1× 105 3.6k
David Varon Israel 32 464 0.5× 104 0.2× 685 1.4× 1.1k 2.4× 230 0.7× 128 4.5k

Countries citing papers authored by Hideki Sakai

Since Specialization
Citations

This map shows the geographic impact of Hideki Sakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Sakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Sakai more than expected).

Fields of papers citing papers by Hideki Sakai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Sakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Sakai. The network helps show where Hideki Sakai may publish in the future.

Co-authorship network of co-authors of Hideki Sakai

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Sakai. A scholar is included among the top collaborators of Hideki Sakai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Sakai. Hideki Sakai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shiota, Masaki, Shuichi Tatarano, Toshiyuki Kamoto, et al.. (2024). Predictive model of castration resistance in advanced prostate cancer by machine learning using genetic and clinical data: KYUCOG-1401-A study. SHILAP Revista de lepidopterología. 2(1). 69–69. 1 indexed citations
2.
Ohba, Kojiro, Takahiro Osawa, Kazutoshi Yamana, et al.. (2023). Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study. International Journal of Urology. 30(11). 977–984. 1 indexed citations
3.
4.
Miyata, Yasuyoshi, Tomohiro Matsuo, Kensuke Mitsunari, et al.. (2020). Relationship Between Stage-specific Embryonic Antigen-4 and Anti-cancer Effects of Neoadjuvant Hormonal Therapy in Prostate Cancer. Anticancer Research. 40(10). 5567–5575. 7 indexed citations
5.
Miyata, Yasuyoshi, Tomohiro Matsuo, Kojiro Ohba, et al.. (2019). A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer. BMC Urology. 19(1). 56–56. 14 indexed citations
6.
Hakariya, Tomoaki, et al.. (2019). Three cases of brain metastasis from castration‐resistant prostate cancer. SHILAP Revista de lepidopterología. 8(1). 96–99. 5 indexed citations
7.
Miyata, Yasuyoshi, Yuichiro Nakamura, Tomohiro Matsuo, et al.. (2017). Neoadjuvant hormonal therapy for low‐risk prostate cancer induces biochemical recurrence after radical prostatectomy via increased lymphangiogenesis‐related parameters. The Prostate. 77(14). 1408–1415. 7 indexed citations
8.
Hakariya, Tomoaki, et al.. (2017). Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years. Clinical Case Reports. 5(4). 425–428. 2 indexed citations
9.
Igawa, Tsukasa, et al.. (2014). Successful treatment for retroperitoneal cavernous hemangioma adjacent to the renal hilum via the laparoscopic approach: a case report. Journal of Medical Case Reports. 8(1). 73–73. 7 indexed citations
10.
11.
Sakai, Hideki, et al.. (2008). Evaluation of carotid artery plaque and restenosis after carotid stenting using virtual histology IVUS. 21(1). 12–17. 2 indexed citations
12.
13.
Wu, Guojun, Madeleine Moussa, Joseph L. Chin, et al.. (2005). Establishment of a Serum Tumor Marker for Preclinical Trials of Mouse Prostate Cancer Models. Clinical Cancer Research. 11(21). 7911–7919. 16 indexed citations
14.
Duan, Wenming, Manal Gabril, Franky Leung Chan, et al.. (2003). Mouse PSP94 expression is prostate tissue‐specific as demonstrated by a comparison of multiple antibodies against recombinant proteins. Journal of Cellular Biochemistry. 88(5). 999–1011. 12 indexed citations
15.
Furuse, Junji, Hiroshi Ishii, Mitsuo Satake, et al.. (2003). Pilot Study of Transcatheter Arterial Chemoembolization with Degradable Starch Microspheres in Patients With Hepatocellular Carcinoma. American Journal of Clinical Oncology. 26(2). 159–164. 33 indexed citations
16.
Sakai, Hideki, Nobuyuki Sakai, Toshio Higashi, et al.. (2002). Current Standard of Endovascular Treatment. Indication and Technical Problems of Stent Placement for Cervical Carotid Artery Stenosis.. Surgery for Cerebral Stroke. 30(5). 339–345.
17.
Kawabata, Yasuhiro, Izumi Nagata, Nobuyuki Sakai, et al.. (2001). Treatment of Bilateral Internal Carotid Artery Stenosis.. Surgery for Cerebral Stroke. 29(5). 339–344. 2 indexed citations
18.
Sakai, Nobuyuki, Izumi Nagata, Ichiro NAKAHARA, et al.. (2001). Treatment Results and Surgical Complications of Asymptomatic Non-ruptured Intracranial Aneurysms.. Surgery for Cerebral Stroke. 29(6). 414–419. 5 indexed citations
19.
Sakai, Hideki, Yuzo Minami, Hiroshi Kanetake, et al.. (1999). A RANDOMIZED TRIAL OF CHEMO-ENDOCRINE THERAPY VERSUS ENDOCRINE THERAPY ALONE IN NEWLY DIAGNOSED PATIENTS WITH ADVANCED PROSTATE CANCER. 61(5). 401–404. 1 indexed citations
20.
Sakai, Hideki. (1999). A Cytoprotective Chloride Channel in Gastric Parietal Cells. YAKUGAKU ZASSHI. 119(8). 584–596.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ettore Mearini Breakdown of academic impact, for papers by Sachiyo Suita Breakdown of academic impact, for papers by Nicola J. Mutch Breakdown of academic impact, for papers by Po‐Hui Chiang Breakdown of academic impact, for papers by E. Kunze Breakdown of academic impact, for papers by Barry S. Oemar Breakdown of academic impact, for papers by Satoshi Suzuki Breakdown of academic impact, for papers by Giovanni Battista Doglietto Breakdown of academic impact, for papers by Hirohiko Yamabe Breakdown of academic impact, for papers by David Varon
Rankless by CCL
2026